Technical Analysis for LMNX - Luminex Corporation

Grade Last Price % Change Price Change
grade C 26.16 2.91% 0.74
LMNX closed up 2.91 percent on Thursday, January 17, 2019, on 85 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Earnings due: Feb 4

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Up
See historical LMNX trend table...

Date Alert Name Type % Chg
Jan 17 Crossed Above 50 DMA Bullish 0.00%
Jan 17 Pocket Pivot Bullish Swing Setup 0.00%
Jan 17 Overbought Stochastic Strength 0.00%
Jan 17 Up 3 Days in a Row Strength 0.00%
Jan 16 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 2.91%
Jan 16 Narrow Range Bar Range Contraction 2.91%
Jan 16 Weak + Overbought Other 2.91%
Jan 16 Overbought Stochastic Strength 2.91%
Jan 15 Stochastic Sell Signal Bearish 3.48%
Jan 15 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 3.48%

Older signals for LMNX ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Luminex Corporation engages in the development, manufacture, and sale of proprietary biological testing technologies and products for the life sciences and diagnostic industries. It offers xMAP technology, an open architecture and multiplexing technology that allows simultaneous analysis of approximately 500 bioassays from a drop of fluid by reading biological tests on the surface of microscopic polystyrene beads called microspheres; and MultiCode technology used for real-time polymerase chain reaction (PCR) and multiplexed PCR assays, as well as automation and robotics in the field of dry sample handling. It operates in two segments, Technology and Strategic Partnerships; and Assays and Related Products. The Technology and Strategic Partnerships segment provides Luminex LX 100/200 that integrates fluidics, optics, and digital signal processing; FLEXMAP 3D system for use as a general laboratory instrument; and MAGPIX system, a multiplexing analyzer for qualitative and quantitative analysis of proteins and nucleic acids. This segment also offers consumables comprising dyed polystyrene microspheres and sheath fluids. The Assays and Related Products segment develops and sells assays on xMAP technology for use on its installed base of systems. This segment's products are focused on the human genetics, personalized medicine, and infectious disease segments of the genetic testing market. This segment provides various assay products, which consist of a combination of chemical and biological reagents, and company's proprietary bead technology used to perform diagnostic and research assays on samples. It serves pharmaceutical companies, clinical laboratories, research institutions, and medical institutions in the United States, Europe, Asia, Canada, and Australia. The company has a collaboration and license agreement with Merck & Co., Inc. to develop a companion diagnostic device. Luminex Corporation was founded in 1995 and is headquartered in Austin, Texas.
Is LMNX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 35.37
52 Week Low 18.62
Average Volume 304,576
200-Day Moving Average 27.4033
50-Day Moving Average 25.8173
20-Day Moving Average 23.6925
10-Day Moving Average 24.751
Average True Range 0.9395
ADX 20.08
+DI 28.3948
-DI 17.6911
Chandelier Exit (Long, 3 ATRs ) 23.3815
Chandelier Exit (Short, 3 ATRs ) 24.0785
Upper Bollinger Band 26.2446
Lower Bollinger Band 21.1404
Percent B (%b) 0.98
BandWidth 21.543526
MACD Line -0.0482
MACD Signal Line -0.4951
MACD Histogram 0.4469
Fundamentals Value
Market Cap 1.15 Billion
Num Shares 44.1 Million
EPS 0.32
Price-to-Earnings (P/E) Ratio 81.75
Price-to-Sales 2.97
Price-to-Book 2.08
PEG Ratio 0.67
Dividend 0.24
Dividend Yield 0.92%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 27.42
Resistance 3 (R3) 27.29 26.75 27.21
Resistance 2 (R2) 26.75 26.43 26.81 27.14
Resistance 1 (R1) 26.45 26.23 26.60 26.58 27.07
Pivot Point 25.91 25.91 25.98 25.97 25.91
Support 1 (S1) 25.61 25.59 25.76 25.74 25.25
Support 2 (S2) 25.07 25.39 25.13 25.18
Support 3 (S3) 24.77 25.07 25.11
Support 4 (S4) 24.90